Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.
Saved in:
| Title: | Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. |
|---|---|
| Authors: | Watkins J; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Weekes D; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Shah V; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Gazinska P; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Joshi S; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Sidhu B; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Gillett C; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom., Pinder S; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom., Vanoli F; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Jasin M; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Mayrhofer M; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Isaksson A; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Cheang MC; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, Surrey, United Kingdom., Mirza H; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Frankum J; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Lord CJ; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Ashworth A; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Vinayak S; Department of Medicine, Stanford University School of Medicine, Stanford, California., Ford JM; Department of Medicine, Stanford University School of Medicine, Stanford, California., Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, California., Grigoriadis A; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Tutt AN; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. andrew.tutt@kcl.ac.uk. |
| Source: | Cancer discovery [Cancer Discov] 2015 May; Vol. 5 (5), pp. 488-505. Date of Electronic Publication: 2015 Mar 13. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
